Colchicine to prevent another brain bleed from CAA
Treatments studied
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests if colchicine can reduce the risk of another stroke caused by bleeding in the brain due to a condition called cerebral amyloid angiopathy (CAA). You may qualify if you've recently had a brain bleed from CAA and have certain signs on brain scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years of age or older.
- You have been diagnosed with probable CAA (a condition where protein builds up in brain blood vessels) based on a brain scan or biopsy.
- You are at high risk for another brain bleed because you have either had one bleed plus a specific brain scan finding (cortical superficial siderosis) or at least two prior bleeds.
- Your most recent brain bleed happened within the last 3 months.
- You are able to complete a brain MRI scan with a special type of imaging (SWI).
- You do not have serious kidney, liver, or blood disorders, and you are not currently taking certain medications that interact with colchicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.
This Phase 2 study tests AMDX-2011P to see if it can help people with cerebral amyloid angiopathy (CAA), a condition where abnormal protein affects blood vessels in the brain. You may be able to join if you have confirmed or likely CAA and a recent brain MRI showing changes from CAA.
This study tests whether the drug LXB (sodium oxybate) can help clear abnormal protein buildup in the brain's small blood vessels (CAA). Participants will take LXB nightly for 8 weeks and have MRIs and spinal taps to measure changes.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This study tests whether colchicine, a medicine that reduces inflammation, can help people recover better and prevent future heart or brain problems after a brain bleed. It may be an option for those with certain health conditions or risk factors.
This Phase 2 trial tests whether colchicine can help people with significant narrowing in brain arteries (from atherosclerosis) after a recent stroke or “mini-stroke.” It aims to reduce the risk related to this condition during the early period after symptoms begin.
Hear when a new Cerebral Amyloid Angiopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.